These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of fluvoxamine on the pharmacokinetics of mexiletine in healthy Japanese men. Kusumoto M; Ueno K; Oda A; Takeda K; Mashimo K; Takaya K; Fujimura Y; Nishihori T; Tanaka K Clin Pharmacol Ther; 2001 Mar; 69(3):104-7. PubMed ID: 11240973 [TBL] [Abstract][Full Text] [Related]
8. Determinants of interindividual variability and extent of CYP2D6 and CYP1A2 inhibition by paroxetine and fluvoxamine in vivo. Ozdemir V; Naranjo CA; Shulman RW; Herrmann N; Sellers EM; Reed K; Kalow W J Clin Psychopharmacol; 1998 Jun; 18(3):198-207. PubMed ID: 9617978 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. Lobo ED; Bergstrom RF; Reddy S; Quinlan T; Chappell J; Hong Q; Ring B; Knadler MP Clin Pharmacokinet; 2008; 47(3):191-202. PubMed ID: 18307373 [TBL] [Abstract][Full Text] [Related]
10. Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6. Ereshefsky L; Riesenman C; Lam YW Clin Pharmacokinet; 1995; 29 Suppl 1():10-8; discussion 18-9. PubMed ID: 8846618 [TBL] [Abstract][Full Text] [Related]
11. Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. Yasui-Furukori N; Takahata T; Nakagami T; Yoshiya G; Inoue Y; Kaneko S; Tateishi T Br J Clin Pharmacol; 2004 Apr; 57(4):487-94. PubMed ID: 15025747 [TBL] [Abstract][Full Text] [Related]
12. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. Isohanni MH; Neuvonen PJ; Olkkola KT Basic Clin Pharmacol Toxicol; 2006 Aug; 99(2):168-72. PubMed ID: 16918719 [TBL] [Abstract][Full Text] [Related]
13. Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine. Jeppesen U; Gram LF; Vistisen K; Loft S; Poulsen HE; Brøsen K Eur J Clin Pharmacol; 1996; 51(1):73-8. PubMed ID: 8880055 [TBL] [Abstract][Full Text] [Related]
14. The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects. Kadokura T; den Adel M; Krauwinkel WJ; Takeshige T; Nishida A Eur J Clin Pharmacol; 2008 Jul; 64(7):691-5. PubMed ID: 18438654 [TBL] [Abstract][Full Text] [Related]
15. The major fluvoxamine metabolite in urine is formed by CYP2D6. Spigset O; Axelsson S; Norström A; Hägg S; Dahlqvist R Eur J Clin Pharmacol; 2001 Nov; 57(9):653-8. PubMed ID: 11791895 [TBL] [Abstract][Full Text] [Related]
16. Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers. Saruwatari J; Yasui-Furukori N; Niioka T; Akamine Y; Takashima A; Kaneko S; Uno T J Clin Psychopharmacol; 2012 Apr; 32(2):195-9. PubMed ID: 22367658 [TBL] [Abstract][Full Text] [Related]
17. Influence of the CYP1A2 inhibitor fluvoxamine on tacrine pharmacokinetics in humans. Becquemont L; Ragueneau I; Le Bot MA; Riche C; Funck-Brentano C; Jaillon P Clin Pharmacol Ther; 1997 Jun; 61(6):619-27. PubMed ID: 9209244 [TBL] [Abstract][Full Text] [Related]
18. The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone. Lamberg TS; Kivistö KT; Laitila J; Mårtensson K; Neuvonen PJ Eur J Clin Pharmacol; 1998; 54(9-10):761-6. PubMed ID: 9923581 [TBL] [Abstract][Full Text] [Related]
19. Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice. Ago Y; Harasawa T; Itoh S; Nakamura S; Baba A; Matsuda T Eur J Pharmacol; 2005 Sep; 520(1-3):86-90. PubMed ID: 16140294 [TBL] [Abstract][Full Text] [Related]
20. Interaction study between fluvoxamine and quazepam. Kanda H; Yasui-Furukori N; Fukasawa T; Aoshima T; Suzuki A; Otani K J Clin Pharmacol; 2003 Dec; 43(12):1392-7. PubMed ID: 14615476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]